Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders

Biological Psychiatry

Volumn 82, Issue 8, 2017, Pages 594-600

  Arion, Dominique ^a   Huo, Zhiguang ^b   Enwright, John F ^a   Corradi, John P ^c   Tseng, George ^b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Bipolar disorder; Major depression; Microarray; Prefrontal cortex; Pyramidal neurons; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MESSENGER RNA; NEUROLEPTIC AGENT; TRANSCRIPTOME;

ARTICLE; BIPOLAR DISORDER; DIAGNOSIS RELATED GROUP; DORSOLATERAL PREFRONTAL CORTEX; ENERGY YIELD; GENE EXPRESSION PROFILING; HUMAN; LASER CAPTURE MICRODISSECTION; MAJOR DEPRESSION; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOSIS; PYRAMIDAL NERVE CELL; RNA TRANSLATION; SCHIZOPHRENIA; SUICIDE; ADULT; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PREFRONTAL CORTEX; PYRAMIDAL CELLS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 85018958965     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2017.03.018     Document Type: Article

References (49)

1. Goldman-Rakic, P.S., Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6 (1994), 348–357.
2. Kahn, R.S., Keefe, R.S., Schizophrenia is a cognitive illness: Time for a change in focus. JAMA Psychiatry 70 (2013), 1107–1112.
3. Millan, M.J., Agid, Y., Brune, M., Bullmore, E.T., Carter, C.S., Clayton, N.S., et al. Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11 (2012), 141–168.
4. Vohringer, P.A., Barroilhet, S.A., Amerio, A., Reale, M.L., Alvear, K., Vergne, D., et al. Cognitive impairment in bipolar disorder and schizophrenia: A systematic review. Front Psychiatry, 4, 2013, 87.
5. Barch, D.M., Sheffield, J.M., Cognitive impairments in psychotic disorders: Common mechanisms and measurement. World Psychiatry 13 (2014), 224–232.
6. Reichenberg, A., Harvey, P.D., Bowie, C.R., Mojtabai, R., Rabinowitz, J., Heaton, R.K., et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 35 (2009), 1022–1029.
7. Bora, E., Pantelis, C., Meta-analysis of cognitive impairment in first-episode bipolar disorder: Comparison with first-episode schizophrenia and healthy controls. Schizophr Bull 41 (2015), 1095–1104.
8. Gatt, J.M., Burton, K.L., Williams, L.M., Schofield, P.R., Specific and common genes implicated across major mental disorders: A review of meta-analysis studies. J Psychiatr Res 60 (2015), 1–13.
9. Mizrahi, R., Social stress and psychosis risk: Common neurochemical substrates?. Neuropsychopharmacology 41 (2016), 666–674.
10. Kuswanto, C.N., Sum, M.Y., Sim, K., Neurocognitive functioning in schizophrenia and bipolar disorder: Clarifying concepts of diagnostic dichotomy vs. continuum. Front Psychiatry, 4, 2013, 162.
11. Arnsten, A.F., The neurobiology of thought: The groundbreaking discoveries of Patricia Goldman-Rakic 1937-2003. Cereb Cortex 23 (2013), 2269–2281.
12. Goldman-Rakic, P.S., Cellular basis of working memory. Neuron 14 (1995), 477–485.
13. Black, J.E., Kodish, I.M., Grossman, A.W., Klintsova, A.Y., Orlovskaya, D., Vostrikov, V., et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 161 (2004), 742–744.
14. Garey, L.J., Ong, W.Y., Patel, T.S., Kanani, M., Davis, A., Mortimer, A.M., et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 65 (1998), 446–453.
15. Rajkowska, G., Selemon, L.D., Goldman-Rakic, P.S., Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55 (1998), 215–224.
16. Glantz, L.A., Lewis, D.A., Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57 (2000), 65–73.
17. Pierri, J.N., Volk, C.L.E., Auh, S., Sampson, A., Lewis, D.A., Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 58 (2001), 466–473.
18. Kolluri, N., Sun, Z., Sampson, A.R., Lewis, D.A., Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 162 (2005), 1200–1202.
19. Konopaske, G.T., Lange, N., Coyle, J.T., Benes, F.M., Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry 71 (2014), 1323–1331.
20. Datta, D., Arion, D., Corradi, J.P., Lewis, D.A., Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry 78 (2015), 775–785.
21. Arion, D., Corradi, J.P., Tang, S., Datta, D., Boothe, F., He, A., et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry 20 (2015), 1397–1405.
22. Fromer, M., Roussos, P., Sieberts, S.K., Johnson, J.S., Kavanagh, D.H., Perumal, T.M., et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci 19 (2016), 1442–1453.
23. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003), 249–264.
24. Galfalvy, H.C., Erraji-Benchekroun, L., Smyrniotopoulos, P., Pavlidis, P., Ellis, S.P., Mann, J.J., et al. Sex genes for genomic analysis in human brain: Internal controls for comparison of probe level data extraction. BMC Bioinformatics, 4, 2003, 37.
25. Wang, X., Lin, Y., Song, C., Sibille, E., Tseng, G.C., Detecting disease-associated genes with confounding variable adjustment and the impact on genomic meta-analysis: With application to major depressive disorder. BMC Bioinformatics, 13, 2012, 52.
26. Storey, J.D., A direct approach to false discovery rates. J R Stat Soc 64 (2002), 479–498.
27. Plaisier, S.B., Taschereau, R., Wong, J.A., Graeber, T.G., Rank-rank hypergenomic overlap: Identification of statistically significant overlap between gene-expression signatures. Nucleic Acids Res, 38, 2010, e169.
28. Horvath, S., Janka, Z., Mirnics, K., Analyzing schizophrenia by DNA microarrays. Biol Psychiatry 69 (2011), 157–162.
29. Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., Buga, A.M., ROS and brain diseases: The good, the bad, and the ugly. Oxid Med Cell Longev, 2013, 2013, 963520.
30. Chu, T.T., Liu, Y., Kemether, E., Thalamic transcriptome screening in three psychiatric states. J Hum Genet 54 (2009), 665–675.
31. Altar, C.A., Jurata, L.W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58 (2005), 85–96.
32. Shao, L., Vawter, M.P., Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 64 (2008), 89–97.
33. Kohen, R., Dobra, A., Tracy, J.H., Haugen, E., Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry, 4, 2014, e366.
34. Huang, J., Perlis, R.H., Lee, P.H., Rush, A.J., Fava, M., Sachs, G.S., et al. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry 167 (2010), 1254–1263.
35. Chang, L.C., Jamain, S., Lin, C.W., Rujescu, D., Tseng, G.C., Sibille, E., A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies. PLoS One, 9, 2014, e90980.
36. Zhao, Z., Xu, J., Chen, J., Kim, S., Reimers, M., Bacanu, S.A., et al. Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 20 (2015), 563–572.
37. Ivleva, E.I., Morris, D.W., Osuji, J., Moates, A.F., Carmody, T.J., Thaker, G.K., et al. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Res 196 (2012), 38–44.
38. Guidotti, A., Auta, J., Davis, J.M., Gerevini, V.D., Dwivedi, Y., Grayson, D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 57 (2000), 1061–1069.
39. Kimoto, S., Zaki, M.M., Bazmi, H.H., Lewis, D.A., Altered markers of cortical gamma-aminobutyric acid neuronal activity in schizophrenia: Role of the NARP gene. JAMA Psychiatry 72 (2015), 747–756.
40. Garbett, K., Gal-Chis, R., Gaszner, G., Lewis, D.A., Mirnics, K., Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide. Neuropsychopharmacol Hung 10 (2008), 9–14.
41. Dean, B., Gibbons, A.S., Boer, S., Uezato, A., Meador-Woodruff, J., Scarr, E., et al. Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide. Aust N Z J Psychiatry 50 (2016), 275–283.
42. Zhao, J., Qi, X.R., Gao, S.F., Lu, J., van Wamelen, D.J., Kamphuis, W., et al. Different stress-related gene expression in depression and suicide. J Psychiatr Res 68 (2015), 176–185.
43. Turecki, G., The molecular bases of the suicidal brain. Nat Rev Neurosci 15 (2014), 802–816.
44. Weinberger, D.R., Berman, K.F., Zec, R.F., Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43 (1986), 114–124.
45. Gonzalez-Burgos, G., Cho, R.Y., Lewis, D.A., Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry 77 (2015), 1031–1040.
46. Glausier, J.R., Lewis, D.A., Dendritic spine pathology in schizophrenia. Neuroscience 251 (2013), 90–107.
47. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
48. Fromer, M., Pocklington, A.J., Kavanagh, D.H., Williams, H.J., Dwyer, S., Gormley, P., et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506 (2014), 179–184.
49. Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506 (2014), 185–190.